Cyclarbamate
A muscle relaxant drug
| Cyclarbamate | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 66-94-4 |
| PubChem | 68648 |
| DrugBank | |
| ChemSpider | 61889 |
| KEGG | |
Cyclarbamate is a carbamate derivative that has been used as a muscle relaxant. It is known for its ability to alleviate muscle spasms and discomfort associated with various musculoskeletal conditions.
Chemical Structure and Properties
Cyclarbamate is chemically classified as a carbamate ester. Its IUPAC name is 2-(2-cyclohexylphenoxy)ethyl carbamate. The molecular formula is C15H21NO3, and it has a molecular weight of 263.33 g/mol. The structure consists of a phenoxy group linked to a cyclohexyl ring, which is further connected to an ethyl carbamate moiety.
Pharmacology
Cyclarbamate functions primarily as a central muscle relaxant. It acts on the central nervous system to reduce muscle tone and alleviate spasms. The exact mechanism of action is not fully understood, but it is believed to involve modulation of neurotransmitter activity in the central nervous system.
Uses
Cyclarbamate has been used in the treatment of muscle spasms and related conditions. It is particularly useful in cases where muscle relaxation is required to relieve pain and improve mobility. However, its use has declined with the development of newer muscle relaxants with improved safety profiles.
Side Effects
As with many muscle relaxants, cyclarbamate can cause side effects such as drowsiness, dizziness, and fatigue. These effects are due to its action on the central nervous system. Patients are advised to avoid activities that require full alertness, such as driving, while taking this medication.
Regulatory Status
Cyclarbamate is not widely used today and may not be available in all countries. Its use has been largely replaced by other muscle relaxants that offer better efficacy and safety.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
